REPORT ID 2440

Asia-Pacific Paclitaxel-eluting Stent Market Report 2017

Publish Date
8-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the Asia-Pacific Paclitaxel-eluting Stent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Paclitaxel-eluting Stent for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Paclitaxel-eluting Stent market competition by top manufacturers/players, with Paclitaxel-eluting Stent sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Vascular
    Advantec Vascular
    B.Braun Melsengen AG
    Biosensors
    Biotronik
    Blue Medical
    Boston Scientific
    DISA Vascular
    Essen
    Medtronic Vascular
    MicroPort Medical
    Terumo Medical
    Orbusneich
    Promed Medical
    Relisys Medical
    Reva Medical
    Sahajanand
    Sorin

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Metal Stent
    Polymer Stent
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Coronary Heart Disease
    Clinical
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Paclitaxel-eluting Stent Market Report 2017
1 Paclitaxel-eluting Stent Overview
    1.1 Product Overview and Scope of Paclitaxel-eluting Stent
    1.2 Classification of Paclitaxel-eluting Stent by Product Category
        1.2.1 Asia-Pacific Paclitaxel-eluting Stent Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Paclitaxel-eluting Stent Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Metal Stent
        1.2.4 Polymer Stent
        1.2.5 Others
    1.3 Asia-Pacific Paclitaxel-eluting Stent Market by Application/End Users
        1.3.1 Asia-Pacific Paclitaxel-eluting Stent Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Coronary Heart Disease
        1.3.3 Clinical
        1.3.4 Others
    1.4 Asia-Pacific Paclitaxel-eluting Stent Market by Region
        1.4.1 Asia-Pacific Paclitaxel-eluting Stent Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Paclitaxel-eluting Stent (2012-2022)
        1.5.1 Asia-Pacific Paclitaxel-eluting Stent Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Paclitaxel-eluting Stent Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Paclitaxel-eluting Stent Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Paclitaxel-eluting Stent Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Paclitaxel-eluting Stent (Volume and Value) by Type
        2.2.1 Asia-Pacific Paclitaxel-eluting Stent Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Paclitaxel-eluting Stent (Volume) by Application
    2.4 Asia-Pacific Paclitaxel-eluting Stent (Volume and Value) by Region
        2.4.1 Asia-Pacific Paclitaxel-eluting Stent Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Market Share by Region (2012-2017)

3 China Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    3.1 China Paclitaxel-eluting Stent Sales and Value (2012-2017)
        3.1.1 China Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        3.1.3 China Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    3.2 China Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    3.3 China Paclitaxel-eluting Stent Sales Volume and Market Share by Application

4 Japan Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    4.1 Japan Paclitaxel-eluting Stent Sales and Value (2012-2017)
        4.1.1 Japan Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    4.2 Japan Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    4.3 Japan Paclitaxel-eluting Stent Sales Volume and Market Share by Application

5 South Korea Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    5.1 South Korea Paclitaxel-eluting Stent Sales and Value (2012-2017)
        5.1.1 South Korea Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    5.2 South Korea Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    5.3 South Korea Paclitaxel-eluting Stent Sales Volume and Market Share by Application

6 Taiwan Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    6.1 Taiwan Paclitaxel-eluting Stent Sales and Value (2012-2017)
        6.1.1 Taiwan Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    6.2 Taiwan Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    6.3 Taiwan Paclitaxel-eluting Stent Sales Volume and Market Share by Application

7 India Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    7.1 India Paclitaxel-eluting Stent Sales and Value (2012-2017)
        7.1.1 India Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        7.1.3 India Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    7.2 India Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    7.3 India Paclitaxel-eluting Stent Sales Volume and Market Share by Application

8 Southeast Asia Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    8.1 Southeast Asia Paclitaxel-eluting Stent Sales and Value (2012-2017)
        8.1.1 Southeast Asia Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    8.2 Southeast Asia Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    8.3 Southeast Asia Paclitaxel-eluting Stent Sales Volume and Market Share by Application

9 Australia Paclitaxel-eluting Stent (Volume, Value and Sales Price)
    9.1 Australia Paclitaxel-eluting Stent Sales and Value (2012-2017)
        9.1.1 Australia Paclitaxel-eluting Stent Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Paclitaxel-eluting Stent Sales Price Trend (2012-2017)
    9.2 Australia Paclitaxel-eluting Stent Sales Volume and Market Share by Type
    9.3 Australia Paclitaxel-eluting Stent Sales Volume and Market Share by Application

10 Asia-Pacific Paclitaxel-eluting Stent Players/Suppliers Profiles and Sales Data
    10.1 Abbott Vascular
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Abbott Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Advantec Vascular
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Advantec Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 B.Braun Melsengen AG
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 B.Braun Melsengen AG Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Biosensors
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Biosensors Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Biotronik
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Biotronik Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Blue Medical
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Blue Medical Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Boston Scientific
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Boston Scientific Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 DISA Vascular
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 DISA Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Essen
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Essen Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Medtronic Vascular
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Paclitaxel-eluting Stent Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 MicroPort Medical
    10.12 Terumo Medical
    10.13 Orbusneich
    10.14 Promed Medical
    10.15 Relisys Medical
    10.16 Reva Medical
    10.17 Sahajanand
    10.18 Sorin

11 Paclitaxel-eluting Stent Manufacturing Cost Analysis
    11.1 Paclitaxel-eluting Stent Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Paclitaxel-eluting Stent

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Paclitaxel-eluting Stent Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Paclitaxel-eluting Stent Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Paclitaxel-eluting Stent Market Forecast (2017-2022)
    15.1 Asia-Pacific Paclitaxel-eluting Stent Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Paclitaxel-eluting Stent Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Paclitaxel-eluting Stent Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Paclitaxel-eluting Stent Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Paclitaxel-eluting Stent Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Paclitaxel-eluting Stent Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Paclitaxel-eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Paclitaxel-eluting Stent Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Paclitaxel-eluting Stent Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Paclitaxel-eluting Stent Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Paclitaxel-eluting Stent Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Paclitaxel-eluting Stent Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer